Dongchedi has completely fallen out with Huawei this time, and the Maextro is basically done for.
Dongchedi spent nearly three million yuan to buy three brand-new Maextro cars for real-world testing.
And all three cars had their brake pedals snap during emergency braking tests.
As soon as the tests were over, Dongchedi realized how serious the problem was. They didn't dare try to hush it up privately; they edited the video overnight and published it across the internet.
The Maextro is priced between 750,000 and 1.5 million yuan and was already highly popular. Once this incident happened, there was no way to cover it up, and the backlash exploded.
You could say that after this test brought the issue to light, even if the Maextro manages to stabilize its reputation, the brand is basically finished and has taken a massive hit.
The success of Bitcoin ETFs is gradually becoming another form of centralization
The success of Bitcoin ETFs is gradually becoming another form of centralization In 2024, the United States officially approved the listing of spot Bitcoin exchange-traded products, marking an important milestone in Bitcoin's entry into traditional financial markets. Large asset management firms, securities companies, and institutional investors can now participate in the Bitcoin market through familiar ETF financial products. From the perspective of market development, this is clear progress. ETFs lower the barrier to investing, reduce operational complexity for some investors, and provide a more convenient way to allocate assets. With active trading
Regulations are becoming increasingly strict, and the gray areas are disappearing. At the same time, more sovereign nations are bringing crypto under legal regulation. If this is the direction things are heading, which coins do you think will have an opportunity? #比特币反弹至8.3万美元
“Preserve your principal, and you’ll never run out of money to spend”: Why is the Collar strategy your enduring moat in a volatile era?
Options can be used to leverage a directional bet, or to secure free insurance for your holdings, Bitcoin investing has another option: use IBIT in combination with options strategies $BTC $IBIT.ETF “Preserve your principal, and you’ll never run out of money to spend”: Why is the Collar strategy your enduring moat in a volatile era? In the U.S. stock market, talk of “doubling your money” and “soaring stocks” always attracts the most attention. But those who survive in the market for decades and steadily build wealth are often not the ones who charge ahead the fastest, but those who manage risk most effectively.
The $105 Oil Price Rhapsody: Geopolitical Tensions, Resurgent Inflation, and the Energy Sector’s Rate-Hike-Resistant Code
The $105 Oil Price Rhapsody: Geopolitical Tensions, Resurgent Inflation, and the Energy Sector’s Rate-Hike-Resistant Code The U.S. Energy Information Administration (EIA) dropped a bombshell in its latest October monthly report, sharply raising its forecast for the average Brent crude price in the fourth quarter by $14 to $105. This move directly reflects the deep fractures geopolitical risks are causing in global supply chains. In futures markets, the battle between bulls and bears has reached a fever pitch. December Brent crude futures settled at $100.58, and despite dipping to $97.06 intraday, the $100 level has proved remarkably resilient as a solid support. This tug-of-war over oil prices, driven by the situation in the Middle East, is not only reshaping the global energy landscape but also injecting enormous uncertainty into the macroeconomy and central bank policy.
When All AIs Choose to Stop Out at Once: Is This the Endgame for Crypto, Triggered by “Collective Rationality”?
When All AIs Choose to Stop Out at Once: Is This the Endgame for Crypto, Triggered by “Collective Rationality”? #AGENT #BianceAlphAlert $BTC In technical analysis and quantitative data processing, human intuition and reaction speed have long paled in comparison to AI. What if we take this trend to its extreme? Suppose that in the future, every trader active on Binance and other major exchanges hands all trading decisions over to highly intelligent AI agents. What would happen? A chilling thought experiment followed: One day, AI detects a weakening macro indicator or a technical breakdown through vast amounts of data, concludes that Bitcoin is about to plunge and drag all altcoins down with it, and millions of AI agents across the network issue “liquidate all positions” orders within the same microsecond.
The UNI token itself has no built-in, hard-coded automatic burn mechanism in its base smart contract (unlike ETH, whose Base Fee is automatically burned with every transaction under EIP-1559). For UNI to generate burns, the following three core conditions must be met: 1. Trigger and activate the “Fee Switch” mechanism (the primary source of ongoing burns) Trigger condition: UNI holders pass a governance vote to activate the protocol fee switch for Uniswap versions (v2 / v3 / v4) or on specific chains. How burning works: 1. By default, 100% of Uniswap’s trading fees go to liquidity providers (LPs).
$3.55 billion in inflows versus high Treasury yields: Is Bitcoin’s 33% quarterly gain a genuine recovery or a false breakout?
$3.55 billion in inflows versus high Treasury yields: Is Bitcoin’s 33% quarterly gain a genuine recovery or a false breakout? Foreword: A stark contrast between strong gains and macroeconomic headwinds Over the past month, the cryptocurrency market has once again displayed its striking “two-sided nature.” On one hand, the latest crypto asset flow data show that global crypto investment funds saw net inflows of as much as $3.55 billion in a single week, helping Bitcoin (BTC), backed by strong buying pressure, post an impressive quarterly gain of nearly 33% and break through—and hold above—a key psychological level. On the other hand, traditional financial markets are gripped by caution: U.S. 10-year Treasury yields remain elevated, and the Federal Reserve’s cautious stance on the path to rate cuts continues to weigh on global risk assets.
Compute Power as an Asset: A New Chapter in “Chip Asset Securitization” from Amazon’s $8 Billion Move
Compute power is an asset: How an $8 billion Amazon play points to a new chapter in “chip asset securitization” As the AI arms race heats up, tech giants are facing unprecedented pressure for capital expenditures. Amazon is currently seeking to pass on Nvidia chips worth as much as $8 billion to investors. This move is not only intended to improve the health of the company’s balance sheet amid soaring AI spending, but also marks a significant turning point in the financialization of technology infrastructure: the securitization of chip assets. An inevitable choice toward a light-asset model
Invest in US stocks with options strategies, no longer worried about the stock market going up and down
$NVDAB It just hit a new high again—are you brave enough to chase it? If you chase, what if it drops and you can’t hold on? I added another 100 shares, then used the collar strategy to lock in a floor of 230 and a ceiling of 300 for 3 years later. Using the Collar strategy to lock in core holdings at the recent high, the main assets won’t be afraid of black swan events. Then, use this to stabilize the margin/guarantee amount, and next, grow new holdings. With options investing, the whole set of moves is really that simple. 1. ATR rotation strategy (standard process: dual-currency wealth management with 3 to 7 day terms) Use the Average True Range (ATR) of the assets to identify a reasonable volatility range, and combine it with dual-currency wealth management products with maturities of 3 to 7 days for high-frequency rotation.
Moderna ($MRNA $MRNAB ) Current cancer vaccines are not directly used to prevent cancer, so not everyone can get the same vaccine. For patients with cancer, normal cells and cancer cells are taken, compared, and then a vaccine customized for the cancer cells is produced. It is mainly used to prevent recurrence after cancer treatment.
The technology is great. But there may not be enough time (cancers that are hard to detect and, once detected, there isn’t much time left).
Customization is very, very expensive and very, very troublesome. So, you’re betting that it will drop.
Cierra Tyler unAW
·
--
When precision medicine meets capital accounting: the “customization” business dilemma of mRNA cancer vaccines
When precision medicine meets capital accounting: the “customization” business dilemma of mRNA cancer vaccines Simply put, today’s cancer vaccines require extreme customization, So even though it’s technically feasible and there’s good news from clinical trials The stock price rockets higher, but I’m bearish—short-term short, long-term bullish. My strategy is to sell puts around 120–130 and prepare to buy back on the dip. The premium is currently very generous! The biotech industry is standing at a crossroads of a medical revolution. The personalized cancer vaccine (INT) co-developed by Moderna and Merck has shown unprecedented anti-cancer potential in clinical data, driving the companies’ stock prices to surge dramatically. However, amid the frenzy comes a different side: bearish warnings from Wall Street analysts and investment institutions. The heart of the controversy isn’t whether the scientific principles hold—it’s that this revolutionary technology is crashing headfirst into an economic wall that’s hard to get around: the limit cost of “customized production.”
Unemployment rises—can the game of capital continue, or is it that old line again: This time it’s different? When the “lights-out factory” runs, who pays? — The macroeconomic paradox of the automation era
When the “lights-out factory” is in operation, who foots the bill? — The macroeconomic paradox of the automation era #美国9月非农仅增2.9万人失业率升至4.2% As unemployment rises, can the game of capital continue? Or is it once again that same line: This time it’s different? In the past century’s economics textbooks, the unemployment rate has always been the most crucial indicator for measuring economic booms and busts. The core logic of traditional Keynesian economics is clear and straightforward: unemployment rises, household total income falls, end-consumer spending shrinks—company revenues decline and they cut capital expenditures \rightarrow fall into a deeper recession spiral. This is the standard pathway of a systemic crisis driven by “insufficient aggregate demand.”
Decoding the Code of Life: How AI Creates a Personalized “Immunology Navigation Map” for Each Cancer Patient
Decoding the Code of Life: How AI Creates a Personalized “Immunology Navigation Map” for Each Cancer Patient The development of AI will bring humanity many unexpected surprises, and one rapidly advancing area is healthcare. Personalized cancer treatment is no longer a dream—it’s already a reality! If you’re also investing in AI stocks, then you should understand AI’s contribution to personalized medicine and the investment outlook. In the long history of fighting cancer, the medical community has long faced a tricky challenge: there are no two tumors in the world that are exactly the same. Even among patients with the same type of cancer, such as melanoma or lung cancer, the combination of genetic mutations in the tumor cells inside their bodies can vary dramatically. This extremely high heterogeneity often means that traditional chemotherapy and targeted drugs—the kind that “treat one drug for a hundred people”—may work initially, only to hit a resistance bottleneck shortly afterward.
When precision medicine meets capital accounting: the “customization” business dilemma of mRNA cancer vaccines
When precision medicine meets capital accounting: the “customization” business dilemma of mRNA cancer vaccines Simply put, today’s cancer vaccines require extreme customization, So even though it’s technically feasible and there’s good news from clinical trials The stock price rockets higher, but I’m bearish—short-term short, long-term bullish. My strategy is to sell puts around 120–130 and prepare to buy back on the dip. The premium is currently very generous! The biotech industry is standing at a crossroads of a medical revolution. The personalized cancer vaccine (INT) co-developed by Moderna and Merck has shown unprecedented anti-cancer potential in clinical data, driving the companies’ stock prices to surge dramatically. However, amid the frenzy comes a different side: bearish warnings from Wall Street analysts and investment institutions. The heart of the controversy isn’t whether the scientific principles hold—it’s that this revolutionary technology is crashing headfirst into an economic wall that’s hard to get around: the limit cost of “customized production.”
Can be understood as setting a limit order. If it doesn’t get filled, you still get your money back. How great is that?
Atlas Markets
·
--
Buffett got paid $7.5M in 1993 to NOT buy Coke stock. That's the setup: sell puts, collect premium, buy shares only if they hit your price.
Berkshire sold 5M put options on $KO at $35 strike when it traded ~$39. If Coke dropped below $35, Berkshire bought at a price Buffett already wanted. If not, they kept the premium. Coke stayed above $35, so Berkshire banked the full $7.5M.
That's a cash-secured put. You don't need Berkshire's balance sheet to run it.
Pick a stock you'd own anyway. Choose a strike below current price. Sell the put, set aside cash for 100 shares, collect premium upfront. Either you get paid to wait or you buy the stock at a discount.
No trading background required. Just a list of names you want to own and the discipline to name your price.
Just because you only look at total volume and think it will keep rising? How about considering those bankrupt, delisted stocks that nobody wants?
Total volume is limited—absolute scarcity
懂币猫
·
--
#BTC In her early years, an old lady bought three color TVs in a rush and hid them under the bed
She was afraid that later, her son wouldn’t be able to afford them when he got married
Back then, color TVs kept rising in price
The logic behind it all is the same
See the trend clearly: Bitcoin has only 21 million coins. Against fiat currency that faces inflation, the long-term trajectory can only be upward. What hurts is that in the next bear market, we most likely won’t be able to see Bitcoin again below 100,000.
Log in to explore more content
Join global crypto users on Binance Square
⚡️ Get latest and useful information about crypto.